These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11761454)

  • 1. Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen.
    Makino M; Shoji H; Takemoto D; Honboh T; Nakamura S; Kurayoshi K; Kaibara N
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):370-4. PubMed ID: 11761454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
    Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
    Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer].
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Fukunaga T; Aihara N
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2077-81. PubMed ID: 14712768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between continuous intravenous and oral administration of 5-FU with LV].
    Iba T; Kidokoro A; Fukunaga M; Momose F; Fuse S; Nagakari K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):631-5. PubMed ID: 10234293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
    Fujita F; Fujita M; Sakamoto Y; Taguchi T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):215-21. PubMed ID: 8382036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo.
    McKeage MJ; Kelland LR; Boxall FE; Valenti MR; Jones M; Goddard PM; Gwynne J; Harrap KR
    Cancer Res; 1994 Aug; 54(15):4118-22. PubMed ID: 8033145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-FU split dose; a phase I/II and pharmacokinetic study of a different schedule of the Nordic regimen in advanced colorectal carcinoma.
    Berglund A; Carlsson G; Gustavsson B; Frödin JE; Ragnhammar P; Glimelius B
    Anticancer Res; 2003; 23(2C):1789-94. PubMed ID: 12820460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer.
    Kobayashi H; Yagyu T; Inagaki K; Kondo T; Suzuki M; Kanayama N; Terao T
    Cancer; 2004 Feb; 100(4):869-77. PubMed ID: 14770446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-fluorouracil].
    Aiba K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1368-79. PubMed ID: 11681244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of combination chemotherapy using oral fluoropyrimidine S-1 with oxaliplatin (SOX) against colorectal cancer in vivo.
    Nukatsuka M; Saito H; Sakamoto K; Nakagawa F; Uchida J; Kobunai T; Shiraishi K; Takechi T
    Anticancer Res; 2012 Jul; 32(7):2807-12. PubMed ID: 22753741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.